Unsaturated phosphatidylcholines lining on the surface of cartilage and its possible physiological roles.
BACKGROUND
Evidence has strongly indicated that surface-active phospholipid (SAPL), or surfactant, lines the surface of cartilage and serves as a lubricating agent. Previous clinical study showed that a saturated phosphatidylcholine (SPC), dipalmitoyl-phosphatidylcholine (DPPC), was effective in the treatment of osteoarthritis, however recent studies suggested that the dominant SAPL species at some sites outside the lung are not SPC, rather, are unsaturated phosphatidylcholine (USPC). Some of these USPC have been proven to be good boundary lubricants by our previous study, implicating their possible important physiological roles in joint if their existence can be confirmed. So far, no study has been conducted to identify the whole molecule species of different phosphatidylcholine (PC) classes on the surface of cartilage. In this study we identified the dominant PC molecule species on the surface of cartilage. We also confirmed that some of these PC species possess a property of semipermeability.


METHODS
HPLC was used to analyse the PC profile of bovine cartilage samples and comparisons of DPPC and USPC were carried out through semipermeability tests.


RESULTS
It was confirmed that USPC are the dominant SAPL species on the surface of cartilage. In particular, they are Dilinoleoyl-phosphatidylcholine (DLPC), Palmitoyl-linoleoyl-phosphatidylcholine, (PLPC), Palmitoyl-oleoyl-phosphatidylcholine (POPC) and Stearoyl-linoleoyl-phosphatidylcholine (SLPC). The relative content of DPPC (a SPC) was only 8%. Two USPC, PLPC and POPC, were capable of generating osmotic pressure that is equivalent to that by DPPC.


CONCLUSIONS
The results from the current study confirm vigorously that USPC is the endogenous species inside the joint as against DPPC thereby confirming once again that USPC, and not SPC, characterizes the PC species distribution at non-lung sites of the body. USPC not only has better anti-friction and lubrication properties than DPPC, they also possess a level of semipermeability that is equivalent to DPPC. We therefore hypothesize that USPC can constitute a possible addition or alternative to the current commercially available viscosupplementation products for the prevention and treatment of osteoarthritis in the future.
Chen
Yi
Y
Orthopedic Research Unit, Prince Charles Hospital, Australia. chen_y2@hotmail.com
Crawford
Ross W
RW
Oloyede
Adekunle
A
Perit Dial Int. 2002 May-Jun;22(3):380-5
12227397
Comp Biochem Physiol A Mol Integr Physiol. 2001 May;129(1):173-82
11369542
Biochem J. 1988 Jul 15;253(2):451-7
3178723
Lancet. 1981 Jan 10;1(8211):64-8
6109119
Biochim Biophys Acta. 1995 Mar 16;1255(2):99-104
7696337
Am J Kidney Dis. 1988 Jul;12(1):31-6
3389351
Eur J Surg. 1995 May;161(5):341-4
7662778
ANZ J Surg. 2005 Dec;75(12):1111-4
16398821
Aust N Z J Surg. 2000 Jun;70(6):443-7
10843402
Aust N Z J Surg. 1999 May;69(5):388-90
10353557
J Appl Physiol (1985). 1992 Sep;73(3):1034-9
1400014
J Rheumatol. 1990 Mar;17(3):349-56
2332857
Perit Dial Int. 2000 Sep-Oct;20(5):503-15
11117241
Ann Otol Rhinol Laryngol. 1972 Apr;81(2):268-71
5067550
J Orthop Res. 2001 Jul;19(4):671-6
11518278
Perit Dial Int. 1998 Mar-Apr;18(2):157-65
9576363
Br J Rheumatol. 1998 Feb;37(2):143-7
9569068
Clin Biomech (Bristol, Avon). 2004 Jun;19(5):534-42
15182990
J Biol Chem. 1957 May;226(1):497-509
13428781
Pharm Res. 2005 Nov;22(11):1926-30
16132340
Am J Med. 1991 Aug 8;91(2A):43S-51S
1882905
Proc Soc Exp Biol Med. 1957 May;95(1):170-2
13432025
Rheumatology (Oxford). 1999 Oct;38(10):1020-1
10534559
Anal Biochem. 1994 Jul;220(1):172-80
7978242
J Lipid Res. 2002 Jan;43(1):99-106
11792728
Br J Rheumatol. 1996 Sep;35(9):821-7
8810664
Pulm Pharmacol Ther. 2006;19(4):292-6
16168690